FDA
approval
· 2021-02-26
FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved Teva's supplemental application for a generic olanzapine and fluoxetine product. The combination is indicated for depressive episodes in bipolar I …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FLUOXETINE)